Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331409
Status:
COMPLETED
Last Update Posted:
2017-10-26
First Post:
2006-05-30
Brief Title:
Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Sponsor:
Organization:
OHSU Knight Cancer Institute